Skip to main content

Table 2 Dosimetric features for high-dose-rate brachytherapy (a) and cyberknife (b)

From: Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy

a

Parameter

Value

CTV

35 (25–43)

D90

106 (106–108)

D100

81 (77–85)

V100

97 (96–98)

V150

24 (22–32)

V200

8 (7–10)

D2 rectum

57 (50–69)

D2 urethra

81 (76–85)

DHI

0.27 (0.22–0.33)

b

Region of interest

Mean (cGy)

Min (cGy)

Max (cGy)

GTV

4027

3462

4375

PTV

3936

3134

4375

Bladder

862

161

3680

Rectum

727

102

3561

Right femoral head

371

145

894

Left femoral head

428

139

1075

  1. Note: CTV clinical target volume, D90 dose delivered to 90% of the CTV, D100 dose delivered to 100% of the CTV, V100 volume receiving 100% of the prescribed dose, V150 volume receiving 150% of the prescribed dose, V200 volume receiving 200% of the prescribed dose, D2 rectum dose delivered to 2% of the rectum volume, D2 urethra dose delivered to 2% of the urethra volume, DHI dose non-homogeneity Index: V150/V100
  2. Note: GTV gross target volume, PTV planning target volume